Application no. and date | 18174165.3 (espacenet) (Federated) (European Patent Register), 20110727 | Patent/reg. no. and date | DK/EP 3434346, 20200902 | Publication date | 20190130 | Priority no. and date | US 36914810 P, 20100730 | EP pub. no. and date |
EP 3434346 20190130 | Effective date | | Applicant/owner | Medimmune Limited, Milstein Building, Granta Park Cambridge CB21 6GH, GB | Applicant ref. no. | SPC345457DK00 | Inventor | SHAH, Ambarish, 18306 Crestmount Road
Boyds, MD 20841, US, SATHISH, Hasige, 12906 Barleycorn Terrace
Germantown, MD 20874, US, LINKE, Thomas, 933 Isaac Chaney Court
Odenton, MD 21113, US, WANG, William, K, 1404 Romeo Court
Mclean, VA 22102, US, HUNTER, Alan, MEDIMMUNE, LLC One MedImmune Way
Gaithersburg, MD 20878, US, THOMPSON, Christopher, MEDIMMUNE, LLC One MedImmune Way
Gaithersburg, MD 20878, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 47/68 (2017.01) , B01D 15/04 (2006.01) , B01J 41/14 (2006.01) , B01J 41/20 (2006.01) , C07K 1/18 (2006.01) , C07K 16/28 (2006.01) | Title | OPRENSEDE AKTIVE POLYPEPTIDER ELLER IMMUNOKONJUGATER | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2021 00027 | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|